Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of type 2 diabetes with incretin-based therapies.

× No keyword cloud information.

11 in total

Review 1. The role of incretins in glucose homeostasis and diabetes treatment.

Authors: Wook Kim; Josephine M Egan
Journal: Pharmacol Rev Date: 2008-12-12 Impact factor: 25.468

Review 2. The unrelenting fall of the pharmacological treatment of obesity.

Authors: Guido Di Dalmazi; Valentina Vicennati; Renato Pasquali; Uberto Pagotto
Journal: Endocrine Date: 2013-05-16 Impact factor: 3.633

Review 3. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.

Authors: Juris J Meier
Journal: Nat Rev Endocrinol Date: 2012-09-04 Impact factor: 43.330

Review 4. The Bidirectional Relationship between Tuberculosis and Diabetes.

Authors: Ernest Yorke; Yacoba Atiase; Josephine Akpalu; Osei Sarfo-Kantanka; Vincent Boima; Ida Dzifa Dey
Journal: Tuberc Res Treat Date: 2017-11-12

Review 5. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot.

Authors: Rahul Pal; Moiz A Ansari; Saif Hameed; Zeeshan Fatima
Journal: Int J Chronic Dis Date: 2016-10-12

Review 6. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Authors: Giuseppe Pugliese; Giuseppe Penno; Andrea Natali; Federica Barutta; Salvatore Di Paolo; Gianpaolo Reboldi; Loreto Gesualdo; Luca De Nicola
Journal: J Nephrol Date: 2020-02 Impact factor: 3.902

7. Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER.

Authors: Véronique Gigoux; Daniel Fourmy
Journal: Front Endocrinol (Lausanne) Date: 2013-04-29 Impact factor: 5.555

Treatment of type 2 diabetes with incretin-based therapies.

Review 1. The role of incretins in glucose homeostasis and diabetes treatment.

Review 2. The unrelenting fall of the pharmacological treatment of obesity.

Review 3. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.

Review 4. The Bidirectional Relationship between Tuberculosis and Diabetes.

Review 5. Diabetes Mellitus as Hub for Tuberculosis Infection: A Snapshot.

7. Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER.

8. Diabetes and tuberculosis: a review of the role of optimal glycemic control.

9. Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.

10. Association of TyG Index with CT Features in Patients with Tuberculosis and Diabetes Mellitus.